Velarion Records
Free. Unsubscribe any time.

Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics, Inc. filed 10 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 10 transactions and 310,520 shares. None carries the SEC's AFF10B5ONE flag; all 10 name a plan in a footnote. 8 results prints are on file in the same window.

What stands out

Trades in Aquestive Therapeutics, Inc. 10

Adoption dates in Aquestive Therapeutics, Inc. 0

Results prints in Aquestive Therapeutics, Inc. 8

Trades before a print in Aquestive Therapeutics, Inc. 0

Interval to Aquestive Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.